Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.07 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.07 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.07 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |